Company intelligence / Profile preview

Sensus Healthcare

Boca Raton, Florida, United Statessensushealthcare.com ↗

Ownership: Public · SRTS
Employees: ~54
Development stage: Commercial

Overview

Sensus Healthcare’s FDA-cleared superficial radiation therapy devices (SRT) are commercially available and widely used for non-invasive treatment of non-melanoma skin cancers and keloids. Clinical studies support their efficacy as a non-surgical alternative, especially for patients unsuitable for surgery or seeking to avoid scarring. The company’s latest product, the SRT‑100 Vision™, adds image-guided capabilities to further improve precision and outcomes.

Therapeutic areas: OncologyDermatology
Modalities: DeviceSuperficial radiation therapy systemBrachytherapy device
Industry: Therapeutic Medical Devices

Financials

Market cap: $51.4M
Total revenue: $2.3M
Enterprise value: $36.5M

Beyond the preview

Go deeper on Sensus Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sensus Healthcare.

Explore the full profile